The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: The Hungarian government's fiscal stimulus initiatives will boost the private consumption of
pharmaceuticals, particularly the over the counter medicines segment. A secondary set of initiatives are
aimed at increasing domestic production capabilities, such as the pharmaceutical sector. While this will
increase competition in the slow-growth domestic medicine market, it may lead to increased incentives for
manufacturers to locate manufacturing facilities in the country as a regional hub.
Headline Expenditure Projections
? Pharmaceuticals: HUF660.8bn (USD2.4bn) in 2015 to HUF667.6bn (USD2.3bn) in 2016; +1.0% in
local currency terms and -1.2% in US dollar terms. Forecast unchanged from last quarter.
? Healthcare: HUF2.5trn (USD9.0bn) in 2015 to HUF2.6trn (USD9.1bn) in 2016; +5.0% in local currency
terms and 2.7% in US dollar terms. Forecast unchanged from last quarter.
While Hungary's Risks score profile is generally predictable, Hungary's Rewards score has improved
considerably due to favourable currency effects and our improving outlook for the country's pharmaceutical